Dario Scimeca - 07 Jun 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
General Counsel and Secretary
Signature
/s/ Dario Scimeca
Issuer symbol
DTIL
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 18:33:01 UTC
Previous filing
07 Mar 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Employee Stock Option (Right to Buy) Award $0 +78,106 $0.000000 78,106 07 Jun 2021 Common Stock 78,106 $11.34 Direct F1
transaction DTIL Restricted Stock Units Award $0 +45,454 $0.000000 45,454 07 Jun 2021 Common Stock 45,454 Direct F2, F3
transaction DTIL Employee Stock Option (Right to Buy) Award $0 +46,629 $0.000000 46,629 07 Jun 2021 Common Stock 46,629 $11.34 Direct F4
transaction DTIL Restricted Stock Units Award $0 +27,136 $0.000000 27,136 07 Jun 2021 Common Stock 27,136 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date. Any unvested options shall vest and become exercisable upon the Reporting Person's termination without cause or resignation due to good reason prior to June 7, 2022.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3 The RSUs shall vest in two substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Any unvested RSUs shall vest upon The Reporting Person's termination without cause or resignation for good reason prior to June 7, 2022.
F4 The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.
F5 The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.